Clinical Trials Logo

Clinical Trial Summary

The total number of the included subjects was 120 in 3 equal groups (RA, OA and control). All subject was subjected to serum IL17 level measurement. MSK US (of both wrists, MCPs, PIPs and DIPs) was done to all patients in RA and OA groups. Disease activity was measured by disease activity score (DAS28) for RA patients. Visual analogue scale for pain (VAS) was obtained from patients in RA and OA groups. Functional assessment was done using health assessment questionnaire (HAQ) for RA patients and the Australian/Canadian (AUSCAN) Osteoarthritis Hand Index for OA patients


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04474912
Study type Observational
Source Zagazig University
Contact
Status Completed
Phase
Start date July 1, 2020
Completion date November 29, 2020